Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold with a ...

Shares of UltraTech Cement Ltd. fell on Friday despite the third quarter numbers being slightly ahead of expectations.

Bharat Petroleum's (BPCL) stock has fallen by 24% since October 2024. Should investors buy BPCL ahead of the Union Budget 2025?

Brokerage firm Nuvama has highlighted concerns about BPCL's weak refining margin environment and LPG under-recoveries, which are impacting its earnings. Additionally, the high capital expenditure ...

CLSA upgraded the stock to 'hold', citing recent corrections, despite inventory losses and weaker refining margins.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 15.45% ...

CLSA analysts upgraded Aurobindo Pharma (NSE:ARBN) (ARBP:IN) stock rating from Hold to Outperform, despite reducing the price target to INR1,400 from INR1,540. The revision reflects a modified ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

Taking a more bearish stance, CLSA has downgraded HUL to an Underperform rating. The brokerage firm also has slashed its ...

Kanzhun Limited (NASDAQ:BZ – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat reports. Four investment ...

There is mild anticipation that as the Snake year slithers in, the local IPO markets will open up, and the STI will hit a new ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...